These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 11244436)

  • 21. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
    Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
    Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmanipulated bone marrow transplantation from one-HLA locus mismatched siblings carries high transplant-related mortality in Chinese patients.
    Leung AY; Lie AK; Au WY; Hawkins BR; Kwong YL; Liang R
    Haematologica; 2001 May; 86(5):518-22. PubMed ID: 11410416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
    Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
    Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors.
    Petersdorf EW; Gooley T; Malkki M; Horowitz M;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():25-30. PubMed ID: 17445158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab.
    Perz JB; Szydlo R; Sergeant R; Sanz J; O'Shea D; Khan T; Davey N; Loaiza S; Davis J; Apperley JF; Olavarria E
    Transpl Immunol; 2007 Nov; 18(2):179-85. PubMed ID: 18005865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection.
    Spencer A; Brookes PA; Kaminski E; Hows JM; Szydlo RM; van Rhee F; Goldman JM; Batchelor JR
    Transplantation; 1995 May; 59(9):1302-8. PubMed ID: 7762066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
    Nagler A; Brautbar C; Slavin S; Bishara A
    Bone Marrow Transplant; 1996 Nov; 18(5):891-7. PubMed ID: 8932842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation.
    Speiser DE; Tiercy JM; Rufer N; Grundschober C; Gratwohl A; Chapuis B; Helg C; Löliger CC; Siren MK; Roosnek E; Jeannet M
    Blood; 1996 May; 87(10):4455-62. PubMed ID: 8639808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
    Oudshoorn M; Doxiadis II; van den Berg-Loonen PM; Voorter CE; Verduyn W; Claas FH
    Hum Immunol; 2002 Mar; 63(3):176-84. PubMed ID: 11872235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre.
    Vossen JM; Donker AE; Heemskerk MB; Lie JL; van Weel-Sipman MH; Bredius RG; Bakker JD; Egeler RM; Oudshoorn M
    Bone Marrow Transplant; 2010 Jan; 45(1):87-95. PubMed ID: 19448680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA; Heilmann C; Madsen HO; Vindeløv LL
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
    Kaminski ER; Hows JM; Bridge J; Davey NJ; Brookes PA; Green JE; Goldman JM; Batchelor JR
    Bone Marrow Transplant; 1991 Jul; 8(1):47-50. PubMed ID: 1912955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
    Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
    Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.
    Rufer N; Tiercy JM; Breur-Vriesendorp B; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Speiser D; Gratwohl A; Chapuis B
    Bone Marrow Transplant; 1995 Nov; 16(5):641-6. PubMed ID: 8547860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
    Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
    Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.